Can a smartphone VR headset distract kids from burn pain?

NCT ID NCT05673551

ENROLLING_BY_INVITATION Symptom relief Sponsor: Nationwide Children's Hospital Source: ClinicalTrials.gov ↗

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This trial tests whether a smartphone-based virtual reality tool (VR-PAT) can reduce pain during at-home burn dressing changes in children aged 6 to 17. Half of the 200 participants will use VR-PAT during their daily dressing changes, while the other half will not. Researchers will compare self-reported and caregiver-reported pain scores to see if VR distraction helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Smartphone-based Virtual Reality Pain Alleviation Tool (VR-PAT) via a lightweight, mobile VR headset
What this could lead to: If effective, VR-PAT could offer a drug-free, at-home option to reduce pain and distress during burn dressing changes for children.
What could go wrong: The trial is relatively small and early, and results may not apply to all children or settings. VR may cause discomfort or not distract enough for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acute Pain burn childhood acute lymphoblastic leukemia injury Pain Pain, Procedural Precursor Cell Lymphoblastic Leukemia-Lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE PAIN BURNS INJURIES PEDIATRIC ALL PROCEDURAL PAIN

Contacts and locations

Locations

Nationwide Children's Hospital

Columbus, Ohio, 43205, United States
Parkland Health & Hospital System

Dallas, Texas, 75235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.